Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TCF25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FCRL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APRT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AATF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ODF2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZCWPW1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMAB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NID1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLOD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIVA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
THADA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IQCH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on